{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:03:25Z","timestamp":1786118605839,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1987,4]]},"DOI":"10.1007\/bf02556177","type":"journal-article","created":{"date-parts":[[2007,2,7]],"date-time":"2007-02-07T14:52:29Z","timestamp":1170859949000},"page":"288-292","source":"Crossref","is-referenced-by-count":44,"title":["Treatment of distal ulcerative colitis with beclomethasone enemas"],"prefix":"10.1097","volume":"30","author":[{"given":"George","family":"Bansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"B\u00fchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Stamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter H.","family":"H\u00e4cki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Buchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrg","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"BF02556177_CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/bmj.1.6003.193","volume":"1","author":"J Powel-Tuck","year":"1976","unstructured":"Powel-Tuck J, Lennard-Jones JE, May CS, Wilson CG, Paterson JW. Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis. Br Med J [Clin Res] 1976;1:193\u20135.","journal-title":"Br Med J [Clin Res]"},{"key":"BF02556177_CR2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/gut.20.5.349","volume":"20","author":"DA Lee","year":"1979","unstructured":"Lee DA, Taylor GM, James VH, Walker G. Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema. Gut 1979;20:349\u201355.","journal-title":"Gut"},{"key":"BF02556177_CR3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/gut.26.8.822","volume":"26","author":"PB McIntyre","year":"1985","unstructured":"McIntyre PB, Macrae FA, Berghouse L, English J, Lennard-Jones JE. Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis. Gut 1985;26:822\u20134.","journal-title":"Gut"},{"key":"BF02556177_CR4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bmj.2.5348.24","volume":"2","author":"SG Matts","year":"1963","unstructured":"Matts SG, Kelleher J, Wharton BA, Walters G. Adrenal cortical and pituitary function after intrarectal steroid therapy. Br Med J [Clin Res] 1963;2:24\u20136.","journal-title":"Br Med J [Clin Res]"},{"key":"BF02556177_CR5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/bmj.3.5776.708-e","volume":"3","author":"JH Jones","year":"1971","unstructured":"Jones JH, Lennard-Jones JE, Misiewicz JJ, et al. Betamethasone 17-valerate and prednisolone 21-phosphate retention enemata in proctocolitis: a multicentre trial. Br Med J [Clin Res] 1971;3:84\u20136.","journal-title":"Br Med J [Clin Res]"},{"key":"BF02556177_CR6","first-page":"753","volume":"67","author":"ET Swarbrick","year":"1974","unstructured":"Swarbrick ET, Loose H, Lennard-Jones JE. Enema volume as an important factor in successful topical corticosteroid treatment of colitis. Proc R Soc Med 1974;67:753\u20134.","journal-title":"Proc R Soc Med"},{"key":"BF02556177_CR7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/gut.21.3.215","volume":"21","author":"DA Lee","year":"1980","unstructured":"Lee DA, Taylor M, James VH, Walker G. Rectally administered prednisolone\u2014evidence for a predominantly local action. Gut 1980;21:215\u20138.","journal-title":"Gut"},{"key":"BF02556177_CR8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/gut.3.4.312","volume":"3","author":"SG Matts","year":"1962","unstructured":"Matts SG. Betamethasone enemata in ulcerative colitis. Gut 1962;3:312\u20134.","journal-title":"Gut"},{"issue":"suppl 4","key":"BF02556177_CR9","first-page":"20","volume":"51","author":"DM Harris","year":"1975","unstructured":"Harris DM. Some properties of beclomethasone dipropionate and related steroids in man. Postgrad Med J 1975;51[suppl 4]:20\u20135.","journal-title":"Postgrad Med J"},{"key":"BF02556177_CR10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2165\/00003495-198428020-00002","volume":"28","author":"RN Brogden","year":"1984","unstructured":"Brogden RN, Heel RC, Speight TM, Avery GS. Beclomethasone dipropionate: a reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 1984;28:99\u2013126.","journal-title":"Drugs"},{"key":"BF02556177_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/cpt1974153267","volume":"15","author":"LE Martin","year":"1974","unstructured":"Martin LE, Tanner RJ, Clark TJ, Cochrane GM. Absorption and metabolism of orally administered beclomethasone dipropionate. Clin Pharmacol Ther 1974;15:267\u201375.","journal-title":"Clin Pharmacol Ther"},{"key":"BF02556177_CR12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(82)91747-0","volume":"1","author":"CR Kumana","year":"1982","unstructured":"Kumana CR, Meghji M, Seaton T, Castelli M, Benson R, Sivakumaran T. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. Lancet 1982;1:579\u201383.","journal-title":"Lancet"},{"key":"BF02556177_CR13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/bmj.1.5375.89","volume":"1","author":"JH Baron","year":"1964","unstructured":"Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J [Clin Res] 1964;1:89\u201392.","journal-title":"Br Med J [Clin Res]"},{"key":"BF02556177_CR14","first-page":"1620","volume":"88","author":"GN Tytgat","year":"1985","unstructured":"Tytgat GN, van der Heide H, van den Brandt-Gradel V, Endert E, Wiersinga W. Comparison of beclomethasone-dipropionate (BDP) and prednisolone 21-phosphate (PP) enemas in distal ulcerative colitis: a double blind study (abstr). Gastroenterology 1985;88:1620.","journal-title":"Gastroenterology"},{"key":"BF02556177_CR15","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/S0016-5085(85)80071-8","volume":"88","author":"DS Levine","year":"1985","unstructured":"Levine DS, Rubin CE. Topical beclomethasone dipropionate enemas improve distal ulcerative colitis and idiopathic proctitis without systemic toxicity (abstr). Gastroenterology 1985;88:1473.","journal-title":"Gastroenterology"},{"key":"BF02556177_CR16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/bmj.2.5104.1072","volume":"2","author":"SC Truelove","year":"1958","unstructured":"Truelove SC. Treatment of ulcerative colitis with local hydrocortisone hemisuccinate sodium: a report on a controlled therapeutic trial. Br Med J [Clin Res] 1958;2:1072\u20137.","journal-title":"Br Med J [Clin Res]"},{"key":"BF02556177_CR17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/bmj.2.5104.1077","volume":"2","author":"G Watkinson","year":"1958","unstructured":"Watkinson G. Treatment of ulcerative colitis with topical hydrocortisone hemisuccinate sodium: a controlled trial employing restricted sequential analysis. Br Med J [Clin Res] 1958;2:1077\u201382.","journal-title":"Br Med J [Clin Res]"},{"key":"BF02556177_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gut.24.3.177","volume":"24","author":"JE Lennard-Jones","year":"1983","unstructured":"Lennard-Jones JE. Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease. Gut 1983;24:177\u201381.","journal-title":"Gut"}],"container-title":["Diseases of the Colon & Rectum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1007\/BF02556177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:19:50Z","timestamp":1786033190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003453-198730040-00018"}},"subtitle":["High therapeutic efficacy without endocrine side effects: A prospective, randomized, double-blind trial"],"short-title":[],"issued":{"date-parts":[[1987,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1987]]}},"URL":"https:\/\/doi.org\/10.1007\/bf02556177","relation":{},"ISSN":["0012-3706"],"issn-type":[{"value":"0012-3706","type":"print"}],"subject":[],"published":{"date-parts":[[1987,4]]}}}